Trial Profile
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin to Reduce the Cholesterol Levels in Outpatients in a Realistic Environment. A Retrospective Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2012
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Ezetimibe/simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 17 Jan 2012 Actual initiation date changed from May 2009 to Apr 2009 as reported by ClinicalTrials.gov.
- 16 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.